| 國立臺灣大學 |
2008 |
Weekly Cisplatin, Infusional High-Dose 5-Fluorouracil and Leucovorin for Advanced, Recurrent and Metastatic Cervical Carcinoma
|
蕭聖謀; 陳祈安; 許駿; 林鶴雄; 謝長堯; 魏凌鴻; HSIAO, SHENG-MOU; CHEN, CHI-AN; HSU, CHIUN; LIN, HO-HSIUNG; HSIEH, CHANG-YAO; WEI, LIN-HUNG |
| 臺大學術典藏 |
2018-09-10T07:13:40Z |
Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma
|
Hsiao, S.-M. and Chen, C.-A. and Hsu, C. and Lin, H.-H. and Hsieh, C.-Y. and Wei, L.-H.; HO-HSIUNG LIN |
| 臺大學術典藏 |
2018-09-10T07:13:59Z |
Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma
|
Hsiao, S.-M. and Chen, C.-A. and Hsu, C. and Lin, H.-H. and Hsieh, C.-Y. and Wei, L.-H.; CHI-AN CHEN |
| 臺大學術典藏 |
2020-04-10T12:51:23Z |
Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma
|
Wei L.-H.; Hsieh C.-Y.; Lin H.-H.; Chiun Hsu; Chen C.-A.; Hsiao S.-M. |
| 臺大學術典藏 |
2022-08-19T00:21:15Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Cheng A.-L.; Wu C.-Y.; Chen J.-S.; Li C.-C.; Liu H.-T.; Hsu C.-H.; Lu Y.-S.; Yeh K.-H.; Yang C.-H.; Shen Y.-C.; CHIUN HSU |
| 臺大學術典藏 |
2018-09-10T04:46:18Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu, C. and Shen, Y.-C. and Yang, C.-H. and Yeh, K.-H. and Lu, Y.-S. and Hsu, C.-H. and Liu, H.-T. and Li, C.-C. and Chen, J.-S. and Wu, C.-Y. and Cheng, A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2004 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Chen J.-S.; Wu C.-Y.; Cheng A.-L.; Li C.-C.; Chiun Hsu;Shen Y.-C.;Yang C.-H.;Yeh K.-H.;Lu Y.-S.;Hsu C.-H.;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Chiun Hsu; Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T. |
| 臺大學術典藏 |
2004 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; CHIH-HUNG HSU; Liu H.-T.; Hsu C.; Hsu C.;Shen Y.-C.;Yang C.-H.;Yeh K.-H.;Lu Y.-S.;Chih-Hung Hsu;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Cheng A.-L.; Wu C.-Y.; Li C.-C.; Chen J.-S. |
| 臺大學術典藏 |
2020-05-26T09:27:29Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C;Shen Y.-C;Chih-Hsin Yang;Yeh K.-H;Lu Y.-S;Hsu C.-H;Liu H.-T;Li C.-C;Chen J.-S;Wu C.-Y;Cheng A.-L.; Hsu C; Shen Y.-C; CHIH-HSIN YANG; Yeh K.-H; Lu Y.-S; Hsu C.-H; Liu H.-T; Li C.-C; Chen J.-S; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:10Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Cheng A.-L.;Wu C.-Y;Chen J.-S;Li C.-C;Liu H.-T;Hsu C.-H;Yen-Shen Lu;Yeh K.-H;Yang C.-H;Shen Y.-C;Hsu C; Hsu C; Shen Y.-C; Yang C.-H; Yeh K.-H; YEN-SHEN LU; Hsu C.-H; Liu H.-T; Li C.-C; Chen J.-S; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:21Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C.; Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-01-28T01:06:50Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C.;Shen Y.-C.;Yang C.-H.;Kun-Huei Yeh;Lu Y.-S.;Hsu C.-H.;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Hsu C.; Shen Y.-C.; Yang C.-H.; KUN-HUEI YEH; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T05:18:40Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C.; Ying-Chun Shen; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; Cheng A.-L. |
| 國家衛生研究院 |
2004-05-04 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu, C; Shen, YC; Yang, CH; Yeh, KH; Lu, YS; Hsu, CH; Liu, HT; Li, CC; Chen, JS; Wu, CY; Cheng, AL |
| 臺大學術典藏 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C;Shen YC;Yang CH;Kun-Huei Yeh;Lu YS;Hsu CH;Liu HT;Li CC;Chen JS;Wu CY;Cheng AL; Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 國立臺灣大學 |
2004-05 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.
|
Hsu C; Shen YC; Yang CH; Kun-Huei Yeh; Lu YS; Hsu CH; Liu HT; Li CC; Chen JS; Wu CY; Cheng AL |
| 國立臺灣大學 |
2004 |
Weekly Gemcitabine Plus 24-Hour Infusion of High-Dose 5-Fluorouracil/ Leucovorin for Locally Advanced or Metastatic Carcinoma of the Biliary Tract.
|
許駿; 沈盈君; 楊志新; 葉坤輝; 盧彥伸; 徐志宏; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; YANG, CHIH-HSIN; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2007-05 |
Weekly paclitaxel and high-dose 5-Fluorouracil plus leucovorin (T-HDFL) in hormone-refractory prostate cancer: in Vitro combined effects and phase II trial
|
Lin, Chia-Chi; Hsu, Chih-Hung; Hour, Tzyh-Chyuan; Cheng, Ann-Lii; Huang, Chao-Yuan; Huang, Kuo-How; Chen, Jun; Pu, Yeong-Shiau |
| 臺大學術典藏 |
2020-05-25T07:35:32Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Chia-Chi Lin; Hsu C.-H; Hour T.-C; Cheng A.-L; Huang C.-Y; Huang K.-H; Chen J; Pu Y.-S. |
| 臺大學術典藏 |
2021-09-01T01:54:32Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Lin C.-C.; Hsu C.-H.; Hour T.-C.; ANN-LII CHENG; Huang C.-Y.; Huang K.-H.; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:03:53Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Lin C.-C.;Hsu C.-H.;Hour T.-C.;Cheng A.-L.;Huang C.-Y.;Kuo-How Huang;Chen J.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; Huang C.-Y.; KUO-HOW HUANG; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:46:57Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Lin C.-C.;Hsu C.-H.;Hour T.-C.;Cheng A.-L.;Huang C.-Y.;Huang K.-H.;Chen J.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; Huang C.-Y.; Huang K.-H.; Chen J.; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-10-14T02:46:14Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Lin C.-C.; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; CHAO-YUAN HUANG; Huang K.-H.; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2022-09-15T01:09:53Z |
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
|
Chia-Chi Lin; Hsu C.-H.; Hour T.-C.; Cheng A.-L.; Huang C.-Y.; Huang K.-H.; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T07:50:57Z |
Weekly pattern of emergency room admissions for peptic ulcers: A population-based study
|
Kao L.-T.; Tsai M.-C.; Lin H.-C.; Pai F.; Lee, Cha-Ze |
